While Basic-Fit made a small profit, in the last year, we think that the market is probably more focussed on the top line growth at the moment. Generally speaking, we'd consider a stock like this ...
With branded wound care manufacturers racing to build out their biologic and tissue-based therapies, AMS could have a hard time penetrating this niche, as it requires a different expertise than ...
AMS Balanced Fund’s total return last month was 1.97% ... A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.